Cebreo Medical Wins CE Mark for In-Ear EEG
The NeuroBuds wearable, which resembles a hearing aid, can record brain activity at home for up to three months.
Updated on Nov. 3, 2026 in Stroke
Live Poll
Would you be willing to use an at-home wearable for long-term medical monitoring?
Cebreo Medical has received CE marking for its NeuroBuds, an in-ear EEG wearable designed for extended ambulatory brain monitoring. The company plans to expand commercial availability across European research and clinical sites.
Why it matters
Conventional EEG monitoring requires a technician to apply a cap of electrodes, which limits recording to controlled settings. An unassisted, discreet device could make long-term brain-activity monitoring more practical for patients in their daily environments.
The manufacturer reports that the device supports monitoring periods of up to three months, compared with conventional EEG systems that depend on a technician-applied electrode cap. Independent clinical validation of the device's performance has not been reported in the source.
The players
Cebreo Medical
Cebreo Medical is the company developing the NeuroBuds in-ear EEG wearable and is pursuing commercial availability in Europe and a future US regulatory pathway.
The details
The NeuroBuds are designed for unassisted use by patients at home and enable multi-day and multi-night recordings in everyday settings. The device is intended to minimize the stigma and burden associated with long-term EEG monitoring by resembling a hearing aid.
Timeline
Cebreo Medical's NeuroBuds received CE marking; the article was published on November 3, 2026.
Legacy Comparison
Long-term EEG monitoring has traditionally depended on technician-applied electrode caps, which confine recording to clinical or laboratory settings. The NeuroBuds, which patients can use unassisted at home for up to three months, represent a shift toward ambulatory brain monitoring in daily life.
For patients who need extended brain monitoring, an in-ear device that can be worn at home could reduce the need for a technician-applied electrode cap during recording. The device's availability and cost in individual markets have not been reported in the source.
The takeaway
Wearable EEG devices that people can use unassisted at home may broaden access to long-term brain monitoring beyond specialized clinical settings. Patients considering such monitoring should ask their clinicians about available options and validation data.
Further reading
For more on the neurological conditions that drive demand for long-term brain monitoring, see Stroke.
Source note: This article includes information reported by Sleep Review.
Live Poll
Would you be willing to use an at-home wearable for long-term medical monitoring?
